San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians


 

Novelties in Lipid Lowering Therapies: Can Statin Therapy Reduce Residual Risk? How Promising Are Icosapent Ethyl, Bampedoic Acid, Inclisiran and Evinacumab for Treating the Patients?

925 views
February 5, 2021
Comments 2
Login to view comments. Click here to Login